Clinical Trials

Showing trials with last updates posted in 2025.

NCT04230304 | TERMINATED | PHASE2
8 participants

Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-30
Start Date:
2020-11-11
Completion:
2023-05-01
Conditions
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
NCT03884998 | ACTIVE_NOT_RECRUITING | PHASE1
27 participants

Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-30
Start Date:
2019-02-26
Completion:
2026-11-04
Conditions
  • Chronic Lymphocytic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Indolent Non-Hodgkin Lymphoma
  • Lymphoplasmacytic Lymphoma
  • Marginal Zone Lymphoma
  • Richter Syndrome
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03605524 | COMPLETED | NA
150 participants

Olfactory Training and Emotional State

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-30
Start Date:
2018-08-28
Completion:
2023-06-27
Conditions
  • Depressive Symptoms
  • Depressive Disorder, Major
Interventions
  • OTHER
No Results Yet
NCT03345420 | COMPLETED | PHASE2
102 participants

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-30
Start Date:
2017-12-12
Completion:
2022-08-30
Conditions
  • Ductal Breast Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Stage 0 Breast Cancer
  • Stage I Breast Cancer
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage II Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
Interventions
  • RADIATION
NCT03199885 | COMPLETED | PHASE3
190 participants

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-30
Start Date:
2019-04-05
Completion:
2024-04-30
Conditions
  • Metastatic Breast Adenocarcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Recurrent Breast Adenocarcinoma
  • Recurrent HER2-Positive Breast Carcinoma
  • Stage III Breast Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Unresectable Breast Carcinoma
  • Unresectable HER2-Positive Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page